Infectivity of West Nile/dengue chimeric viruses for West Nile and dengue mosquito vectors

Vector-Borne and Zoonotic Diseases

Volumn 5, Issue 1, 2005, Pages 1-10

  Hanley, Kathryn A ^a,d   Goddard, Laura B ^b   Gilmore, Lara E ^c   Scott, Thomas W ^b   Speicher, James ^a   Murphy, Brian R ^a   Pletnev, Alexander G ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^d NEW MEXICO STATE UNIVERSITY   (United States)

Author keywords

Dengue virus; Mosquito; West Nile virus

Indexed keywords

VIRUS VACCINE; VIRUS VECTOR; HYBRID PROTEIN; LIVE VACCINE;

AEDES AEGYPTI; AEDES ALBOPICTUS; ANIMAL CELL; ARTICLE; ATTENUATION; CHIMERA; CONTROLLED STUDY; CULEX; DENGUE VIRUS; HEAD; HOST; MIDGUT; MOSQUITO; NONHUMAN; PRIORITY JOURNAL; SALIVA; SPECIES COMPARISON; STATISTICAL SIGNIFICANCE; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS TRANSMISSION; VIRUS TYPING; WEST NILE FLAVIVIRUS; WILD TYPE; AEDES; ANIMAL; CERCOPITHECUS; DENGUE; DISEASE CARRIER; DISEASE TRANSMISSION; HUMAN; IMMUNOLOGY; PATHOGENICITY; SPECIES DIFFERENCE; VERO CELL; VIROLOGY;

CULEX TARSALIS; DENGUE VIRUS; WEST NILE VIRUS;

AEDES; ANIMALS; CERCOPITHECUS AETHIOPS; CULEX; CULICIDAE; DENGUE; DENGUE VIRUS; HUMANS; INSECT VECTORS; RECOMBINANT FUSION PROTEINS; SPECIES SPECIFICITY; VACCINES, ATTENUATED; VERO CELLS; VIRAL VACCINES; WEST NILE FEVER; WEST NILE VIRUS;

EID: 19644379091     PISSN: 15303667     EISSN: None     Source Type: Journal    
DOI: 10.1089/vbz.2005.5.1     Document Type: Article

References (38)

1. Anonymous. Update: West Nile activity - eastern United States. MMWR Morb Mortal Wkly Rep 2000; 49:1044-1047.
2. Anonymous. West Nile virus activity - United States, November 20-25, 2003. MMWR Morb Mortal Wkly Rep 2003; 52:1160.
3. Beaty, BJ, Holterman, M, Tabachnick, W, et al. Molecular basis of bunyavirus transmission by mosquitoes: role of the middle-sized RNA segment. Science 1981; 211: 1433-1435.
4. Beaty, BJ, Miller, BR, Shope, RE, et al. Molecular basis of bunyavirus per os infection of mosquitoes: role of the middle-sized RNA segment. Proc Natl Acad Sci U S A 1982; 79:1295-1297.
5. Bellamy, RE, Kardos, EH. A strain of Culex tarsalis Coq. reproducing wtihout blood meals. Mosq News 1958; 18:132-134.
6. Blaney, JE, Manipon, GG, Firestone, CY, et al. Mutations which enhance the replication of dengue virus type 4 and an antigenic chimeric dengue virus type 2/4 vaccine candidate in Vero cells. Vaccine 2003; 21: 4317-4327.
7. Brault, AC, Powers, AM, Weaver, SC. Vector infection determinants of Venezuelan equine encephalitis virus reside within the E2 envelope glycoprotein. J Virol 2002; 76:6387-6392.
8. Brinton, MA. The molecular biology of West Nile Virus: a new invader of the western hemisphere. Annu Rev Microbiol 2002; 56:371-402.
9. Bunning, ML, Bowen, RA, Cropp, CB, et al. Experimental infection of horses with West Nile virus. Emerg Infect Dis 2002; 8:380-386.
10. Campbell, GL, Marfin, AA, Lanciotti, RS, et al. West Nile virus. Lancet Infect Dis 2002; 2:519-529.
11. Durbin, AP, Karron, RA, Sun, W, et al. Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3′-untranslated region. Am J Trop Med Hyg 2001; 65:405-413.
12. Goddard, LB, Roth, AE, Reisen, WK, et al. Vector competence of California mosquitoes for West Nile virus. Emerg Infect Dis 2002; 8:1385-1391.
13. Hanley, KA, Manlucu, LR, Gilmore, LE, et al. A trade-off in replication in moquito versus mammalian systems conferred by a point mutation in the NS4B protein of dengue virus type 4. Virology 2003; 312:222-232.
14. Hardy, JL, Houk, EJ, Kramer, JD, et al. Intrinsic factors affecting vector competence of mosquitoes for arboviruses. Annu Rev Entomol 1983; 28:229-262.
15. Hayes, CG. West Nile fever. In: Monath TP, ed. The Arboviruses: Epidemiology and Ecology. Boca Raton, FL: CRC Press; 1989:59-88.
16. Huber, K, Loan, LL, Hoang, TH, et al. Temporal genetic variation in Aedes aegypti populations in Ho Chi Minh City (Vietnam). Heredity 2002; 89:7-14.
17. Iwamoto, M, Jernigan, DB, Guasch, A, et al. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med 2003; 348:2196-2203.
18. Jirakanjanakit, N, Khin, MM, Yoksan, S, et al. Dynamics of susceptibility and transmissibility of the live, attenuated, candidate vaccines dengue-1 PDK13, dengue-3 PGMK30F3, and dengue-4 PDK48 after oral infection in Aedes aegypti. Am J Trop Med Hyg 1999; 61:672-676.
19. Komar, N, Langevin, S, Hinten, S, et al. Experimental infection of North American birds with the New York 1999 strain of West Nile virus. Emerg Infect Dis 2003; 9:311-322.
20. Kutz, FW, Wade, TG, Pagac, BB. A geospatial study of the potential of two exotic species of mosquitoes to impact the epidemiology of West Nile virus in Maryland. J Am Mosq Control Assoc 2003; 19:190-198.
21. Leyssen, P, Charlier, N, Lemey, P, et al. Complete genome sequence, taxonomic assignment, and comparative analysis of the untranslated regions of the Modoc virus, a flavivirus with no known vector. Virology 2002; 293:125-140.
22. Olson, KE, Myles, KM, Seabaugh, RC, et al. Development of a Sindbis virus expression system that efficiently expresses green fluorescent protein in midguts of Aedes aegypti following per os infection. Insect Mol Biol 2000; 9:57-65.
23. Paupy, C, Chantha, N, Vazeille, M, et al. Variation over space and time of Aedes aegypti in Phnom Penh (Cambodia): genetic structure and oral susceptibility to a dengue virus. Genet Res 2003; 82:171-182.
24. Pletnev, AG, Claire, MS, Elkins, R, et al. Molecularly engineered live-attenuated chimeric West Nile/dengue virus vaccines protect rhesus monkeys from West Nile virus. Virology 2003; 314:190-195.
25. Pletnev, AG, Putnak, R, Speicher, J, et al. West Nile virus/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy. Proc Natl Acad Sci U S A 2002; 99:3036-3041.
26. Rice, CM. Flaviviridae: The viruses and their replication. In: Fields BN, Knipe DM, Howley PM, et al., eds. Fields Virology, 3rd ed. Philadelphia: Lippincott-Raven Publishers; 1996:931-959.
27. Rodhain, F, Rosen, L. Mosquito vectors and dengue virus-vector relationships. In: Gubler DJ, Kunc, G, eds. Dengue and Dengue Hemorrhagic Fever. New York: CAB International; 1997:45-60.
28. Rosen, L, Roseboom, LE, Gubler, DJ, et al. Comparative susceptibility of mosquito species and strains to oral and parenteral infection with dengue and Japanese encephalitis viruses. Am J Trop Med Hyg 1985; 34: 603-615.
29. Sardelis, MR, Turell, MJ, O'Guinn, ML, et al. Vector competence of three North American strains of Aedes albopictus for West Nile virus. J Am Mosq Control Assoc 2002; 18:284-289.
30. Sundin, DR, Beaty, BJ, Nathanson, N, et al. A G1 glycoprotein epitope of La Crosse virus: a determinant of infection of Aedes triseriatus. Science 1987, 235:591-593.
31. Troyer, JM, Hanley, KA, Whitehead, SS, et al. A live attenuated recombinant dengue-4 virus vaccine candidate with restricted capacity for dissemination in mosquitoes and lack of transmission from vaccinees to mosquitoes. Am J Trop Med Hyg 2001; 65:414-419.
32. Turell, MJ, O'Guinn, ML, Dohm, DJ, et al. Vector competence of North American mosquitoes (Diptera: Culicidae) for West Nile virus. J Med Entomol 2001; 38: 130-134.
33. Turell, MJ, Sardelis, MR, Dohm, DJ, et al. Potential North American vectors of West Nile virus. Ann N Y Acad Sci 2001; 951:317-324.
34. Turell, MJ, O'Guinn, ML, Dohm, DJ, et al. Vector competence of Culex tarsalis from Orange County, California, for West Nile virus. Vector-Borne Zoonotic Dis 2002; 2:193-196.
35. Vazeille, M, Rosen, L, Mousson, L, et al. Low oral receptivity for dengue type 2 viruses of Aedes albopictus from Southeast Asia compared with that of Aedes aegypti. Am J Trop Med Hyg 2003; 68:203-208.
36. Weaver, SC, Lorenz, LH, Scott, TW. Distribution of western equine encephalomyelitis virus in the alimentary tract of Culex tarsalis (Diptera: Culicidae) following natural and artificial blood meals. J Med Entomol 1993; 30:391-397.
37. Whitehead, SS, Hanley, KA, Blaney, JE, et al. Substitution of the structural genes of dengue virus type 4 with those of type 2 results in chimeric vaccine candidates which are attenuated for mosquitoes, mice, and rhesus monkeys. Vaccine 2003; 21:4307-4316.
38. Woodward, TM, Miller, BR, Beaty, BJ, et al. A single amino acid change in the E2 glycoprotein of Venezuelan equine encephalitis virus affects replication and dissemination in Aedes aegypti mosquitoes. J Gen Virol 1991; 72:2431-2435.